Search research articles
Contact Us
Filters
Showing results (41-50 of 58) with videos related to
Page
of 6
Sort By:
Journal of Thrombosis and Haemostasis : JTH
|
December 20, 2005
Modulation of TAFI function through different pathways--implications for the development of TAFI inhibitors
A Gils, E Ceresa, A M Macovei, et al.
New Biotechnology
|
February 18, 2015
Ara h 1 protein-antibody dissociation study: evidence for binding inhomogeneities on a molecular scale
E Pérez-Ruiz, D Spasic, A Gils, et al.
Thrombosis and Haemostasis
|
May 25, 2001
Elucidation of the binding regions of PAI-1 neutralizing antibodies using chimeric variants of human and rat PAI-1
A P Bijnens, T H Ngo, A Gils, et al.
Journal of Thrombosis and Haemostasis : JTH
|
October 23, 2012
The hyperfibrinolytic state of mice with combined thrombin-activatable fibrinolysis inhibitor (TAFI) and plasminogen activator inhibitor-1 gene deficiency is critically dependent on TAFI deficiency
E Vercauteren, M Peeters, M F Hoylaerts, et al.
Journal of Thrombosis and Haemostasis : JTH
|
October 10, 2007
Development of sandwich-type ELISAs for the quantification of rat and murine thrombin activatable fibrinolysis inhibitor in plasma
K Hillmayer, E Brouwers, F León-Tamariz, et al.
Alimentary Pharmacology & Therapeutics
|
October 4, 2014
Prior response to infliximab and early serum drug concentrations predict effects of adalimumab in ulcerative colitis
F Baert, N Vande Casteele, S Tops, et al.
The Journal of Biological Chemistry
|
September 18, 2001
The distal hinge of the reactive site loop and its proximity: a target to modulate plasminogen activator inhibitor-1 activity
A P Bijnens, A Gils, J M Stassen, et al.
Journal of Thrombosis and Haemostasis : JTH
|
September 3, 2011
TAFIa inhibiting nanobodies as profibrinolytic tools and discovery of a new TAFIa conformation
M L V Hendrickx, A DE Winter, K Buelens, et al.
Alimentary Pharmacology & Therapeutics
|
August 30, 2012
Detection of infliximab levels and anti-infliximab antibodies: a comparison of three different assays
N Vande Casteele, D J Buurman, M G G Sturkenboom, et al.
Journal of Thrombosis and Haemostasis : JTH
|
August 24, 2017
Thrombin-activatable fibrinolysis inhibitor in human abdominal aortic aneurysm disease
K I Bridge, L Bollen, J Zhong, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 58) with videos related to
Sort By:
Page
of 6
Journal of Thrombosis and Haemostasis : JTH
|
December 20, 2005
Modulation of TAFI function through different pathways--implications for the development of TAFI inhibitors
A Gils, E Ceresa, A M Macovei, et al.
New Biotechnology
|
February 18, 2015
Ara h 1 protein-antibody dissociation study: evidence for binding inhomogeneities on a molecular scale
E Pérez-Ruiz, D Spasic, A Gils, et al.
Thrombosis and Haemostasis
|
May 25, 2001
Elucidation of the binding regions of PAI-1 neutralizing antibodies using chimeric variants of human and rat PAI-1
A P Bijnens, T H Ngo, A Gils, et al.
Journal of Thrombosis and Haemostasis : JTH
|
October 23, 2012
The hyperfibrinolytic state of mice with combined thrombin-activatable fibrinolysis inhibitor (TAFI) and plasminogen activator inhibitor-1 gene deficiency is critically dependent on TAFI deficiency
E Vercauteren, M Peeters, M F Hoylaerts, et al.
Journal of Thrombosis and Haemostasis : JTH
|
October 10, 2007
Development of sandwich-type ELISAs for the quantification of rat and murine thrombin activatable fibrinolysis inhibitor in plasma
K Hillmayer, E Brouwers, F León-Tamariz, et al.
Alimentary Pharmacology & Therapeutics
|
October 4, 2014
Prior response to infliximab and early serum drug concentrations predict effects of adalimumab in ulcerative colitis
F Baert, N Vande Casteele, S Tops, et al.
The Journal of Biological Chemistry
|
September 18, 2001
The distal hinge of the reactive site loop and its proximity: a target to modulate plasminogen activator inhibitor-1 activity
A P Bijnens, A Gils, J M Stassen, et al.
Journal of Thrombosis and Haemostasis : JTH
|
September 3, 2011
TAFIa inhibiting nanobodies as profibrinolytic tools and discovery of a new TAFIa conformation
M L V Hendrickx, A DE Winter, K Buelens, et al.
Alimentary Pharmacology & Therapeutics
|
August 30, 2012
Detection of infliximab levels and anti-infliximab antibodies: a comparison of three different assays
N Vande Casteele, D J Buurman, M G G Sturkenboom, et al.
Journal of Thrombosis and Haemostasis : JTH
|
August 24, 2017
Thrombin-activatable fibrinolysis inhibitor in human abdominal aortic aneurysm disease
K I Bridge, L Bollen, J Zhong, et al.
Page
of 6